3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
52
OTHER
47
NIH
17
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Head and Neck Neoplasms
1
Interventions
Radiotherapy
87
Cyclophosphamide
84
Cisplatin
79
Doxorubicin
66
Vincristine
62
Paclitaxel
55
Etoposide
50
Carboplatin
49
Filgrastim
48
Methotrexate
41
Prednisone
40
Cytarabine
37
Granulocyte Colony-Stimulating Factor
35
Radiotherapy, Intensity-Modulated
31
Platinum
31
Docetaxel
31
Gemcitabine
30
Leucovorin
28
Dexamethasone
28
Radiotherapy, Conformal
27
Fluorouracil
27
Cetuximab
26
Taxes
24
Rituximab
23
Irinotecan
23
1,2-diaminocyclohexaneplatinum II citrate
23
Radiation
21
merphos
20
Bevacizumab
19
Temozolomide
18
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Has results
×
Lapatinib
×
Clear all
NCT01711658
2023-10-17
TRYHARD
Radiation Therapy Oncology Group
Phase 2
Completed
142 enrolled
22 charts